«

»

FDA approves first breakthrough-designated test to detect extensive number of cancer biomarkers

CMS said it would cover the test to make the targeted therapy options available to healthcare professionals, patients and eligible Medicare beneficiaries‎.

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive